A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Please provide your email address to receive an email when new articles are posted on . Miller-Owen: Close to 8 million U.S. residents with diabetes are on insulin therapy, and the clear majority use ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. What part of the phrase ‘risk of spreading blood-borne disease’ did the ...

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...

(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the potential for ...

This new prefilled insulin injection pen has a unique spring-loaded mechanism. The pen has a no push-button extension at any dose and a low injection force, designed to make self-injecting easier for ...

One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Brown leatherette covered hinged case ...